3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
Clinical trial NCT05265052 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05265052
- Sponsor
- 3D Medicines
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.